Solventum Corporation is an American healthcare company that was created as a spin-off from 3M on April 1, 2024. The decision to separate the healthcare division from 3M was made to streamline operations and focus on specific areas such as wound and oral care, health informatics, and biopharmaceutical filtration.
The spin-off of Solventum followed a trend of other industrial conglomerates undergoing similar splits in recent years. Companies like General Electric, Johnson & Johnson, Kellogg’s, and Toshiba have all made similar moves to restructure their business operations.
The new company, Solventum, was officially registered in Delaware in January 2023 and was unveiled as a portmanteau of “solving” and “momentum” in November 2023. Bryan Hanson was appointed as the first CEO of Solventum in September 2023.
On February 25, 2025, it was announced that Thermo Fisher Scientific would acquire Solventum’s Purification & Filtration business unit for $4.1B, further reshaping the company’s operations.
With 3M retaining a minority stake in Solventum, the healthcare company is poised for future growth and innovation in the healthcare industry under the leadership of CEO Bryan Hanson.
Attribution:
This article was summarized and republished from the original source.
Please check the original article here: https://en.wikipedia.org/wiki/Solventum.